Klotho Neurosciences, INC. (GRMLW) — 8-K Filings

8-K Filings (34)

• 8-K Filing — Dec 8, 2025
• Klotho Neurosciences Faces Delisting Concerns — Sep 25, 2025 Risk: high
  Klotho Neurosciences, Inc. filed an 8-K on September 25, 2025, reporting a notice of delisting or failure to satisfy a continued listing rule or standard as of
• Klotho Neurosciences Files 8-K: Material Agreement — Aug 12, 2025 Risk: medium
  Klotho Neurosciences, Inc. entered into a Material Definitive Agreement on August 6, 2025. The company, formerly known as ANEW Medical, Inc. and Redwoods Acquis
• Klotho Neurosciences Enters Material Definitive Agreement — Jul 22, 2025 Risk: medium
  Klotho Neurosciences, Inc. announced on July 16, 2025, that it entered into a Material Definitive Agreement. The company, formerly known as ANEW Medical, Inc. a
• Klotho Neurosciences Faces Delisting Concerns — Jul 18, 2025 Risk: high
  Klotho Neurosciences, Inc. filed an 8-K on July 18, 2025, reporting a notice of delisting or failure to satisfy continued listing rules. The company, formerly k
• Klotho Neurosciences Files 8-K — Jul 10, 2025 Risk: low
  Klotho Neurosciences, Inc. filed an 8-K on July 10, 2025, reporting a Regulation FD Disclosure and Financial Statements and Exhibits. The company, formerly know
• Klotho Neurosciences Files 8-K — Jun 30, 2025 Risk: low
  Klotho Neurosciences, Inc. filed an 8-K on June 30, 2025, reporting a Regulation FD Disclosure and Financial Statements and Exhibits. The company, formerly know
• Klotho Neurosciences Files 8-K — Jun 16, 2025 Risk: low
  Klotho Neurosciences, Inc. filed an 8-K on June 16, 2025, reporting on other events and financial statements. The company, formerly known as ANEW Medical, Inc.
• Klotho Neurosciences Reports Material Agreement & Equity Sales — Jun 13, 2025 Risk: medium
  Klotho Neurosciences, Inc. filed an 8-K on June 13, 2025, reporting on events that occurred on June 9, 2025. The filing indicates an entry into a material defin
• Klotho Neurosciences Files 8-K on Agreements — Jun 11, 2025 Risk: medium
  Klotho Neurosciences, Inc. filed an 8-K on June 11, 2025, reporting on an entry into a material definitive agreement and unregistered sales of equity securities
• Klotho Neurosciences Enters Material Definitive Agreement — Jun 10, 2025 Risk: medium
  Klotho Neurosciences, Inc. announced on June 5, 2025, that it entered into a Material Definitive Agreement. The company, formerly known as Redwoods Acquisition
• Klotho Neurosciences Files 8-K on Shareholder Votes & Financials — Jun 2, 2025 Risk: low
  Klotho Neurosciences, Inc. filed an 8-K on May 28, 2025, reporting on the submission of matters to a vote of security holders and financial statements. The comp
• Klotho Neurosciences Faces Nasdaq Delisting Warning — Apr 21, 2025 Risk: high
  Klotho Neurosciences, Inc. has received a notice from the Nasdaq Stock Market indicating that the company is not in compliance with the minimum bid price requir
• Klotho Neurosciences, Inc. Files 8-K, Details Name Changes — Apr 4, 2025 Risk: low
  Klotho Neurosciences, Inc. filed an 8-K on April 4, 2025, reporting an event on March 31, 2025. The filing indicates the company's former names were ANEW Medica
• Klotho Neurosciences Files 8-K for Material Agreement — Apr 1, 2025 Risk: medium
  Klotho Neurosciences, Inc. filed an 8-K on April 1, 2025, reporting a material definitive agreement entered into on March 26, 2025. The filing also includes fin
• Klotho Neurosciences Faces Delisting Notice — Feb 24, 2025 Risk: high
  Klotho Neurosciences, Inc. filed an 8-K on February 24, 2025, reporting a notice of delisting or failure to meet continued listing standards as of February 14,
• Klotho Neurosciences Enters Material Agreement, Reports Financial Obligations — Jan 24, 2025 Risk: medium
  Klotho Neurosciences, Inc. announced on January 23, 2025, that it entered into a material definitive agreement. The company also reported the creation of a dire
• Klotho Neurosciences Reports Definitive Agreement & Equity Sales — Dec 10, 2024 Risk: medium
  Klotho Neurosciences, Inc. entered into a material definitive agreement on December 4, 2024, related to the creation of a direct financial obligation. The compa
• Klotho Neurosciences Reports Director/Officer Changes & Financials — Nov 25, 2024 Risk: medium
  Klotho Neurosciences, Inc. filed an 8-K on November 25, 2024, reporting events as of November 19, 2024. The filing pertains to the departure of directors or cer
• Klotho Neurosciences Terminates Material Agreement — Nov 13, 2024 Risk: medium
  Klotho Neurosciences, Inc. reported the termination of a material definitive agreement on November 8, 2024. The company, formerly known as ANEW Medical, Inc. an
• Klotho Neurosciences Files 8-K on Officer/Director Changes — Oct 31, 2024 Risk: medium
  Klotho Neurosciences, Inc. filed an 8-K on October 31, 2024, reporting events that occurred on October 24, 2024. The filing pertains to the departure of directo
• Klotho Neurosciences Faces Delisting Concerns — Oct 21, 2024 Risk: high
  Klotho Neurosciences, Inc. filed an 8-K on October 21, 2024, reporting a notice of delisting or failure to satisfy continued listing rules as of October 14, 202
• Klotho Neurosciences Files 8-K — Oct 2, 2024 Risk: low
  Klotho Neurosciences, Inc. filed an 8-K on October 2, 2024, reporting an event on September 24, 2024. The company, formerly known as ANEW Medical, Inc. and Redw
• ANEW Medical Announces Board and Executive Changes — Aug 30, 2024 Risk: medium
  On August 25, 2024, ANEW Medical, Inc. filed an 8-K report detailing changes in its board of directors and executive officers. The filing includes information o
• ANEW Medical Faces Delisting Concerns — Aug 22, 2024 Risk: high
  ANEW Medical, Inc. (formerly Redwoods Acquisition Corp.) filed an 8-K on August 22, 2024, reporting a notice of delisting or failure to satisfy continued listin
• ANEW Medical Appoints New CMO, Director — Aug 5, 2024 Risk: medium
  On July 30, 2024, ANEW Medical, Inc. announced the appointment of Dr. David L. Smith as Chief Medical Officer and the election of Ms. Jennifer L. Smith to its B
• ANEW Medical Completes Major Transaction, Changes Control — Jun 27, 2024 Risk: high
  On June 21, 2024, ANEW Medical, Inc. (formerly Redwoods Acquisition Corp.) completed a significant transaction, entering into a material definitive agreement an
• Redwoods Acquisition Corp. Files 8-K — Jun 20, 2024 Risk: low
  Redwoods Acquisition Corp. filed an 8-K on June 20, 2024, reporting on other events and financial statements. The company, incorporated in Delaware, is involved
• Redwoods Acquisition Corp. Files Material Definitive Agreement — May 10, 2024 Risk: medium
  On May 9, 2024, Redwoods Acquisition Corp. filed an 8-K report detailing a material definitive agreement. The company, incorporated in Delaware with its princip
• Redwoods Acquisition Corp. Files 8-K on Shareholder Votes — Apr 18, 2024 Risk: low
  Redwoods Acquisition Corp. filed an 8-K on April 18, 2024, reporting on matters submitted to a vote of security holders and a Regulation FD disclosure. The fili
• Redwoods Acquisition Corp. Files 8-K — Apr 12, 2024 Risk: low
  Redwoods Acquisition Corp. filed an 8-K on April 12, 2024, reporting an event on April 8, 2024. The filing pertains to their status as a SPAC (Special Purpose A
• Redwoods Acquisition Corp. Files 8-K on Corporate Structure Changes — Apr 5, 2024 Risk: low
  Redwoods Acquisition Corp. filed an 8-K on April 5, 2024, reporting an event on April 1, 2024. The filing indicates changes related to its units, common stock,
• Redwoods Acquisition Corp. Files 8-K — Mar 22, 2024 Risk: low
  Redwoods Acquisition Corp. filed an 8-K on March 22, 2024, to report other events. The company, incorporated in Delaware, is involved in the biological products
• Redwoods Acquisition Corp. Files 8-K on Corporate Structure — Mar 11, 2024 Risk: low
  Redwoods Acquisition Corp. filed an 8-K on March 11, 2024, reporting an event that occurred on March 8, 2024. The filing pertains to the company's structure, in

Popular Companies

AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX